Cite
Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major.
MLA
Olivieri, Nancy F., et al. “Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major.” New England Journal of Medicine, vol. 339, no. 7, Aug. 1998, pp. 417–23. EBSCOhost, https://doi.org/10.1056/NEJM199808133390701.
APA
Olivieri, N. F., Brittenham, G. M., McLaren, C. E., Templeton, D. M., Cameron, R. G., McClelland, R. A., Burt, A. D., & Fleming, K. A. (1998). Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major. New England Journal of Medicine, 339(7), 417–423. https://doi.org/10.1056/NEJM199808133390701
Chicago
Olivieri, Nancy F., Gary M. Brittenham, Christine E. McLaren, Douglas M. Templeton, Ross G. Cameron, Robert A. McClelland, Alastair D. Burt, and Kenneth A. Fleming. 1998. “Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major.” New England Journal of Medicine 339 (7): 417–23. doi:10.1056/NEJM199808133390701.